GL1X · GenesisL1 explorer

MolNFT v1 · #16141 · protein

Tr receptor mutations conferring hormone resistance and reduced corepressor release exhibit decreased stability in the nterminal lbd

1NQ0 · Thyroid hormone receptor beta-1: “Tr receptor mutations conferring hormone resistance and reduced corepressor release exhibit decreased…”. X-ray diffraction, 2 ligands (4HY, ARS), 3 pockets (best druggability 0.82). MolNFT v1 #16141…

PDB
1NQ0
Type
protein
Length
253 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thyroid hormone receptor beta-1
UniProt
P10828
Ligands
4HY, ARS
Pockets
3 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 67% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThyroid hormone receptor beta-1protein25367% helix, 4% strandP10828

Ligands and binding sites

  • 4HY · [4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]-acetic acid · ligand · chains A
  • ARS · Arsenic · metal · 6 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11990.820.96314HY
21250.450.7720empty
31090.370.7416empty

Compared structures

  • 1NQ0 · TR Receptor Mutations Conferring Hormone Resistance and Reduced Corepressor Release… · the same entry in another collection · chain A against A, TM-score 1.00
  • P10828 · AlphaFold monomer V2.0 prediction for thyroid hormone receptor beta (P10828) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.